References
- Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012;3(3):243–250. doi:10.4161/viru.19700.
- Aydemir H, Tuz HI, Piskin N, Celebi G, Kulah C, Kokturk F. Risk factors and clinical responses of pneumonia patients with colistin-resistant Acinetobacter baumannii-calcoaceticus. World J Clin Cases. 2019;7(10):1111–1121. doi:10.12998/wjcc.v7.i10.1111.
- Xu A, Zhu H, Gao B, et al. Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report. BMC Infect Dis. 2020;20:45. doi:10.1186/s12879-019-4733-5.
- Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317. doi:10.1086/421946.
- Misbah S, AbuBakar S, Hassan H, Hanifah YA, Yusof MY. Antibiotic susceptibility and REP-PCR fingerprints of Acinetobacter spp. isolated from a hospital ten years apart. J Hospital Infect. 2004 Dec;58(4):254–261. doi:10.1016/j.jhin.2004.07.007.
- World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed [Internet]. Geneva: WHO; 2017. https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-newantibiotics-are-urgently-needed. Accessed March 9, 2020
- Liu AR, Du WJ, Xie JF, et al. Role of immunodeficiency in Acinetobacter baumannii associated pneumonia in mice. Chin Med J (Engl). 2020;133(18):2161–2169. doi:10.1097/CM9.0000000000001027.
- Alsulaiman D, Al-Hamed N, Alziadi A, et al. Evaluation of Acinetobacter baumannii pneumonia among critically ill patients in a tertiary care hospital in Saudi Arabia. Heliyon. 2020;6(5):e03976. Published 2020 May 20. doi:10.1016/j.heliyon.2020.e03976.
- Corradino B, Toia F, Di Lorenzo S, Cordova A, Moschella F. A difficult case of necrotizing fasciitis caused by Acinetobacter baumannii. Int J Low Extrem Wounds. 2010;9(4):152–154. doi:10.1177/1534734610389598.
- Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35(11):2819–2825. doi:10.1128/jcm.35.11.2819-2825.1997.
- Pereira TDSF, Travassos DV, Silva RCC, et al. Acinetobacter baumannii orofacial cellulitis: report of 2 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(6):e118–e122. doi:10.1016/j.oooo.2019.02.012.
- Talreja D, Muraleedharan C, Gunathilaka G, et al. Virulence properties of multidrug resistant ocular isolates of Acinetobacter baumannii. Curr Eye Res. 2014;39(7):695–704. doi:10.3109/02713683.2013.873055.
- Chen KJ, Sun MH, Hou CH, et al. Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin. Sci Rep. 2021;11(1):15878. Published 2021 Aug 5. doi:10.1038/s41598-021-95458-w.
- Roy R, Panigrahi P, Malathi J, et al. Endophthalmitis caused by Acinetobacter baumannii: a case series. Eye (Lond). 2013;27(3):450–452. doi:10.1038/eye.2012.277.
- Bitirgen G, Ozkagnici A, Kerimoglu H, Kamis U. Acute postoperative endophthalmitis with an unusual infective agent: Acinetobacter baumannii. J Cataract Refract Surg. 2013;39:143–144. doi:10.1016/j.jcrs.2012.10.026.
- Chen KJ, Hou CH, Sun MH, Lai CC, Sun CC, Hsiao CH. Endophthalmitis caused by Acinetobacter baumannii: report of two cases. J Clin Microbiol. 2008 Mar;46(3): 1148–1150.